CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported a loss of $568,000 in its fourth quarter.
The Canton, Massachusetts-based company said it had a loss of less than 1 cent on a per-share basis.
The regenerative medicine company posted revenue of $99.7 million in the period.
For the year, the company reported profit of $4.9 million, or 4 cents per share. Revenue was reported as $433.1 million.
Advertisement
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO
Advertisement